Evaluation of simultaneous permeation and metabolism of methyl nicotinate in human, snake, and shed snake skin

Pharmaceutical Development and Technology

Volumn 13, Issue 1, 2008, Pages 75-83

  Ngawhirunpat, Tanasait ^a   Opanasopit, Praneet ^a   Rojanarata, Theerasak ^a   Panomsuk, Suwannee ^a   Chanchome, Lawan ^b  

^a SILPAKORN UNIVERSITY   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

Author keywords

Esterase; Shed snake skin; Skin metabolism; Species difference

Indexed keywords

ESTERASE; NICOTINIC ACID; NICOTINIC ACID METHYL ESTER;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG PENETRATION; ELAPHAE OBSOLETA; HUMAN; HUMAN TISSUE; IN VITRO STUDY; NAJA KAOUTHIA; NONHUMAN; PRIORITY JOURNAL; PYTHON MOLURUS; SKIN PENETRATION; SNAKE; STRATUM CORNEUM; TISSUE HOMOGENATE;

ALGORITHMS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL TRANSPORT, ACTIVE; COBRA; HUMANS; HYDROLYSIS; NICOTINIC ACIDS; SKIN; SKIN ABSORPTION; SNAKES;

EID: 39749175491     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450701703105     Document Type: Article

References (27)

1. Bando S, Mohri F, Yamashita Y, Takakura F, Hashida M. Effect of skin metabolism on percutaneous absorption of lipophilic drugs. J. Pharm. Sci. 1997;86:759-761.
2. Mukai E, Arase K, Hashida M, Sezaki H. Enhanced delivery of mitomicin C prodrugs through the skin. Int. J. Pharm. 1985;25:95-103.
3. Chan SY, Po LW. Prodrug for dermal delivery. Int. J. Pharm. 1987;55:1-16.
4. Itoh T, Xia J, Magavi R, Nishihata T, Rytting JH. Use of shed snake skin as a model membrane for in vitro percutaneous penetration studies: comparison with human skin. Pharm. Res. 1990;7:1042-1047.
5. Hirvonen JH, Rytting JH, Paronen P, Urtti A. Dodecyl N,N-dimethylamino acetate and azone enhance drug permeation across human, snake and rabbit skin. Pharm. Res. 1991;8:933-937.
6. Harada K, Murakami T, Kawasaki E, Higashi Y, Yamamoto S, Yata N. In vitro permeability to salicylic acid of human, rodent, and shed snake skin. J. Pharm. Pharmacol. 1993;45: 414-418.
7. Pongjanyakul T, Prakongpan S, Priprem A. Permeation studies comparing cobra skin with human skin using nicotine transdermal patches. Drug. Dev. Ind. Pharm. 2000;26:635-642.
8. Pongjanyakul T. Prakongpan S, Panomsuk S, Puttipipatkhachorn S, Priprem A. Shed king cobra and cobra skins as model membrane for in vitro nicotine permeation studies. J. Pharm. Pharmacol. 2002;54:1345-1350.
9. Haigh JM, Beyssac E, Chanet L, Aiache JM. In vitro permeation of progesterone from gel through the shed snake skin of three different snake species. Int. J. Pharm. 1998;170:151-156.
10. Nghiem BT, Higuchi T. Esterase activity in shed snake skin. Int. J. Pharm. 1988;44:125-130.
11. Ngawhirunpat T, Panomsuk S, Opanasopit P, Rojanarata T, Hatanaka T. Comparison of the percutaneous absorption of hydrophilic and lipophilic compounds in shed snake skin and human skin. Pharmazie. 2006;61:331-335.
12. OECD. Skin absorption: In vitro method. In: OECD New Guideline Proposal on In Vitro Percutaneous Absorption of Chemicals. Test Guideline 428. Paris: OECD;2001.
13. Burger S, Murray S, Gaines KF, Novak JF, Punshon T, Dixon C. Element levels in snakes in South Carolina: differences between a control site and exposed site on the Savannah River Site. Environ. Monit. Assess. 2006;112:35-52.
14. Opanasopit P, Panomsuk S, Ngawhirunpat T, Meeim K, Suratannont J, Tannikkul C. Development and evaluation of polymeric matices for isosorbide dinitrate transdermal drug delivery systems. Thai. J. Pharm. Sci. 2001;22:125-136.
15. Hatanaka T, Inuma M, Sugibayashi K, Morimoto Y. Prediction of skin permeability of drugs I: Comparison with artificial membrane. Chem. Pharm. Bull. 1990;38:3452-3459.
16. Bronaugh RL, Stewart RF, Simon M. Methods for in vitro percutaneous absorption studies. VII. Use of excised human skin. J. Pharm. Sci. 1986;75:1094-1097.
17. Bronaugh RL, Stewart RF, Storm JE. Extent of cutaneous metabolism during percutaneous absorption of xenobiotics. Toxicol. Appl. Pharmacol. 1989;99:534-543.
18. Knutson K, Potts RO, Guzek DB, Golden GM, Mckie JE, Lambert WJ, Higuchi WI. Macro and molecular physicalchemical consideration in understanding drug transport in stratum corneum. J. Control. Rel. 1985;2:67-87.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951;193:265-275.
20. Rittirod T, Hatanaka T, Uraki A, Hino K, Katayama, K Koizumi T. Species difference in skin transport and metabolism of ethyl nicotinate in skin. Int. J. Pharm. 1999;178:161-169.
21. Ngawhirunpat T, Hatanaka T, Kawakami J, Adachi I. Age difference in simultaneous permeation and metabolism of ethyl nicotinate in rat skin. Biol. Pharm. Bull. 2001;24:414-417.
22. Takahashi K, Tamagawa S, Katagi T, Rytting H, Nishihata T, Mizuno N. Percutaneous absorption of basic compounds through shed snake skin as model membrane. J. Pharm. Pharmacol. 1993;45:882-886.
23. Sato K, Sugibayashi K, Morimoto Y. Species differences in percutaneous absorption of nicorandil. J. Pharm. Sci. 1991;80:104-107.
24. Dick IP, Scott RC. The influence of different strains and age on in vitro rat skin permeation to water and mannitol. Pharm. Res. 1992;9:884-887.
25. Martin RJ, Denyer P, Hadgraft, J. Skin metabolism of topically applied compound. Int. J. Pharm. 1987;39:23-32.
26. Tojo K, Yamada K, Hikima T. Diffusion and metabolism of prednisolone fanesylate in viable skin of the hairless mouse. Pharm. Res. 1994;11:393-397.
27. Sugibayashi K, Hayashi T, Hatanaka T, Ogihara M, Morimoto Y. Analysis of simultaneous transport and metabolism of ethyl nicotinate in hairless rat skin. Pharm. Res. 1996;13:855-860.